logo







Home>Companies>Ikena-oncology-nas-ikna


Ikena oncology (nas: ikna)

Ikena oncology (nas: ikna)



Ikena Oncology (NAS: IKNA) is a biotechnology company focused on developing precision therapies that target cancer growth, spread, and resistance mechanisms within the Hippo and RAS onco-signaling networks.
Sign up today to get real-time market insights on Ikena oncology (nas: ikna) and hundreds of other pre-IPO companies



Ikena oncology (nas: ikna) Overview

Boston, MA, United States
2014
Energy
https://www.ikenaoncology.com



Ikena oncology (nas: ikna) Live Market Data

$00000000
$00000000




Ikena oncology (nas: ikna) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO3/26/2021
Series B1/5/2021
Early Stage VC1/18/2019
Series A12/14/2017
Accelerator/Incubator4/14/2017




Ikena oncology (nas: ikna) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Atlas VentureSeries A, Series BSeries A (2017-12-14)
Bristol-Myers Squibb (NYS: BMY)Early Stage VC, Series BEarly Stage VC (2019-01-18)




Ikena oncology (nas: ikna) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Ikena oncology (nas: ikna) data




Ikena oncology (nas: ikna) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Ikena oncology (nas: ikna) data




Latest Ikena oncology (nas: ikna) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.